| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Stomach Neoplasms | 39 | 2024 | 1458 | 7.500 |
Why?
|
| Esophageal Neoplasms | 33 | 2024 | 1658 | 5.220 |
Why?
|
| Esophagogastric Junction | 19 | 2024 | 347 | 4.330 |
Why?
|
| Cardia | 9 | 2020 | 60 | 3.190 |
Why?
|
| Barrett Esophagus | 26 | 2024 | 492 | 3.150 |
Why?
|
| Adenocarcinoma | 32 | 2024 | 6340 | 2.810 |
Why?
|
| Gastric Mucosa | 10 | 2021 | 603 | 1.910 |
Why?
|
| Lymphatic Metastasis | 17 | 2023 | 2913 | 1.840 |
Why?
|
| Carcinoma | 9 | 2020 | 2328 | 1.410 |
Why?
|
| China | 22 | 2019 | 2374 | 1.240 |
Why?
|
| Stomach | 5 | 2018 | 697 | 1.140 |
Why?
|
| Lymphangioma | 2 | 2019 | 61 | 0.970 |
Why?
|
| Gastrectomy | 14 | 2022 | 671 | 0.960 |
Why?
|
| Brunner Glands | 1 | 2023 | 11 | 0.890 |
Why?
|
| Esophagus | 8 | 2015 | 1033 | 0.860 |
Why?
|
| Duodenal Neoplasms | 1 | 2023 | 114 | 0.840 |
Why?
|
| Neoplasm Staging | 23 | 2018 | 11118 | 0.820 |
Why?
|
| Adenocarcinoma, Papillary | 2 | 2022 | 84 | 0.820 |
Why?
|
| Cholangiocarcinoma | 2 | 2018 | 554 | 0.790 |
Why?
|
| Bile Duct Neoplasms | 2 | 2018 | 607 | 0.780 |
Why?
|
| Heart Neoplasms | 2 | 2021 | 364 | 0.700 |
Why?
|
| Endoscopy, Gastrointestinal | 8 | 2016 | 876 | 0.660 |
Why?
|
| Pyloric Antrum | 2 | 2018 | 66 | 0.640 |
Why?
|
| Receptors, G-Protein-Coupled | 5 | 2014 | 1249 | 0.620 |
Why?
|
| Gastritis | 3 | 2015 | 199 | 0.600 |
Why?
|
| Tomography, Optical Coherence | 14 | 2020 | 2923 | 0.590 |
Why?
|
| Genes, p16 | 1 | 2018 | 160 | 0.580 |
Why?
|
| Adenoma | 5 | 2023 | 2159 | 0.580 |
Why?
|
| Neoplasm Invasiveness | 10 | 2022 | 3591 | 0.570 |
Why?
|
| Pancreas | 2 | 2016 | 1685 | 0.560 |
Why?
|
| Carcinosarcoma | 1 | 2018 | 106 | 0.560 |
Why?
|
| Neoplasms, Complex and Mixed | 1 | 2017 | 35 | 0.560 |
Why?
|
| Choristoma | 2 | 2016 | 205 | 0.560 |
Why?
|
| Esophageal Diseases | 3 | 2012 | 168 | 0.550 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2018 | 212 | 0.540 |
Why?
|
| Gene Amplification | 2 | 2018 | 1084 | 0.540 |
Why?
|
| Kaplan-Meier Estimate | 10 | 2024 | 6482 | 0.540 |
Why?
|
| Immunohistochemistry | 19 | 2018 | 11066 | 0.540 |
Why?
|
| Pancreatitis | 1 | 2023 | 1097 | 0.530 |
Why?
|
| Prognosis | 20 | 2024 | 29672 | 0.510 |
Why?
|
| Esophagoscopy | 10 | 2019 | 398 | 0.500 |
Why?
|
| In Situ Hybridization, Fluorescence | 2 | 2018 | 2508 | 0.490 |
Why?
|
| Aged, 80 and over | 29 | 2024 | 58946 | 0.480 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2018 | 696 | 0.480 |
Why?
|
| Receptor, erbB-2 | 3 | 2014 | 2553 | 0.470 |
Why?
|
| Digestive System Diseases | 1 | 2016 | 151 | 0.470 |
Why?
|
| Carcinoma, Neuroendocrine | 2 | 2013 | 339 | 0.470 |
Why?
|
| Aged | 54 | 2024 | 169266 | 0.470 |
Why?
|
| Cadherins | 2 | 2016 | 902 | 0.470 |
Why?
|
| Middle Aged | 60 | 2024 | 220835 | 0.460 |
Why?
|
| Metaplasia | 7 | 2020 | 324 | 0.460 |
Why?
|
| Survival Rate | 17 | 2023 | 12727 | 0.460 |
Why?
|
| Gastroscopy | 4 | 2016 | 211 | 0.460 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2020 | 614 | 0.450 |
Why?
|
| Helicobacter Infections | 5 | 2020 | 391 | 0.440 |
Why?
|
| STAT3 Transcription Factor | 1 | 2017 | 872 | 0.420 |
Why?
|
| Genomic Instability | 1 | 2017 | 709 | 0.420 |
Why?
|
| Male | 81 | 2024 | 360675 | 0.410 |
Why?
|
| Biopsy | 10 | 2020 | 6781 | 0.410 |
Why?
|
| Neoplastic Stem Cells | 2 | 2017 | 1348 | 0.400 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2017 | 610 | 0.400 |
Why?
|
| Pancreaticoduodenectomy | 1 | 2015 | 509 | 0.390 |
Why?
|
| Genetic Markers | 1 | 2018 | 2599 | 0.390 |
Why?
|
| Pathology, Clinical | 1 | 2015 | 376 | 0.380 |
Why?
|
| Carcinoma, Transitional Cell | 1 | 2018 | 782 | 0.370 |
Why?
|
| Sirtuin 1 | 4 | 2013 | 246 | 0.370 |
Why?
|
| Carcinoma in Situ | 2 | 2015 | 791 | 0.370 |
Why?
|
| Medulla Oblongata | 6 | 1997 | 248 | 0.370 |
Why?
|
| Humans | 104 | 2024 | 761098 | 0.360 |
Why?
|
| Female | 67 | 2024 | 392458 | 0.360 |
Why?
|
| Precancerous Conditions | 7 | 2018 | 982 | 0.360 |
Why?
|
| Cell Movement | 2 | 2019 | 5195 | 0.350 |
Why?
|
| Jejunal Neoplasms | 1 | 2009 | 19 | 0.330 |
Why?
|
| Tumor Suppressor Protein p53 | 3 | 2016 | 2914 | 0.310 |
Why?
|
| Peutz-Jeghers Syndrome | 1 | 2008 | 60 | 0.310 |
Why?
|
| Receptors, Estrogen | 1 | 2016 | 2208 | 0.310 |
Why?
|
| Colorectal Neoplasms | 5 | 2018 | 6919 | 0.290 |
Why?
|
| Interleukin-6 | 1 | 2017 | 3210 | 0.280 |
Why?
|
| Adult | 35 | 2020 | 221083 | 0.280 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2013 | 4021 | 0.280 |
Why?
|
| Polyps | 1 | 2008 | 200 | 0.280 |
Why?
|
| Hamartoma | 1 | 2008 | 236 | 0.270 |
Why?
|
| Retrospective Studies | 21 | 2023 | 80673 | 0.270 |
Why?
|
| Helicobacter pylori | 3 | 2020 | 381 | 0.270 |
Why?
|
| Disease Progression | 8 | 2017 | 13506 | 0.260 |
Why?
|
| beta Catenin | 2 | 2015 | 1039 | 0.260 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2014 | 2820 | 0.260 |
Why?
|
| Carcinoid Tumor | 3 | 2012 | 224 | 0.260 |
Why?
|
| Neuroendocrine Tumors | 1 | 2012 | 641 | 0.260 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2018 | 2223 | 0.250 |
Why?
|
| Tumor Burden | 4 | 2019 | 1892 | 0.240 |
Why?
|
| Ki-67 Antigen | 4 | 2015 | 627 | 0.240 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2017 | 2293 | 0.230 |
Why?
|
| Lymph Node Excision | 5 | 2022 | 1269 | 0.220 |
Why?
|
| Respiratory Mechanics | 3 | 1997 | 699 | 0.210 |
Why?
|
| Epithelial-Mesenchymal Transition | 2 | 2018 | 736 | 0.210 |
Why?
|
| Risk Factors | 12 | 2024 | 74219 | 0.190 |
Why?
|
| Duodenum | 2 | 2023 | 491 | 0.190 |
Why?
|
| HSP90 Heat-Shock Proteins | 2 | 2015 | 422 | 0.190 |
Why?
|
| Liver Neoplasms | 1 | 2017 | 4308 | 0.190 |
Why?
|
| Proportional Hazards Models | 6 | 2017 | 12467 | 0.190 |
Why?
|
| Gastroesophageal Reflux | 2 | 2023 | 821 | 0.190 |
Why?
|
| Gene Expression Regulation, Neoplastic | 5 | 2018 | 8529 | 0.180 |
Why?
|
| Phrenic Nerve | 6 | 1997 | 79 | 0.170 |
Why?
|
| Capsule Endoscopy | 1 | 2020 | 102 | 0.170 |
Why?
|
| Age Distribution | 2 | 2016 | 2873 | 0.160 |
Why?
|
| Lymph Nodes | 4 | 2017 | 3461 | 0.160 |
Why?
|
| Gastric Fundus | 1 | 2018 | 37 | 0.160 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2013 | 2423 | 0.160 |
Why?
|
| Esophagectomy | 2 | 2020 | 469 | 0.150 |
Why?
|
| World Health Organization | 2 | 2015 | 1321 | 0.150 |
Why?
|
| Longitudinal Studies | 2 | 2024 | 14607 | 0.140 |
Why?
|
| Imaging, Three-Dimensional | 6 | 2014 | 4060 | 0.140 |
Why?
|
| Colonic Neoplasms | 3 | 2014 | 2528 | 0.140 |
Why?
|
| Ploidies | 2 | 2008 | 285 | 0.140 |
Why?
|
| Goblet Cells | 1 | 2020 | 298 | 0.140 |
Why?
|
| Predictive Value of Tests | 5 | 2017 | 15308 | 0.140 |
Why?
|
| Respiration | 5 | 1996 | 1656 | 0.140 |
Why?
|
| Sex Factors | 3 | 2016 | 10552 | 0.130 |
Why?
|
| Cerebellum | 3 | 1993 | 1501 | 0.130 |
Why?
|
| Ascorbic Acid | 1 | 2019 | 654 | 0.130 |
Why?
|
| Treatment Outcome | 10 | 2023 | 64670 | 0.130 |
Why?
|
| Mucous Membrane | 3 | 2019 | 659 | 0.130 |
Why?
|
| Cystadenoma | 1 | 2015 | 79 | 0.130 |
Why?
|
| Necrosis | 2 | 2018 | 1611 | 0.130 |
Why?
|
| Intestinal Mucosa | 3 | 2013 | 3030 | 0.130 |
Why?
|
| Antigens, Tumor-Associated, Carbohydrate | 1 | 2016 | 138 | 0.130 |
Why?
|
| Hazardous Substances | 1 | 2016 | 153 | 0.120 |
Why?
|
| Oxyphil Cells | 1 | 2015 | 56 | 0.120 |
Why?
|
| Quinolinic Acid | 1 | 1995 | 67 | 0.120 |
Why?
|
| Endoscopy, Digestive System | 3 | 2012 | 353 | 0.120 |
Why?
|
| Herpesvirus 4, Human | 1 | 2020 | 1076 | 0.120 |
Why?
|
| Choledocholithiasis | 1 | 2015 | 50 | 0.120 |
Why?
|
| Cats | 7 | 1994 | 974 | 0.120 |
Why?
|
| Hepatitis B virus | 1 | 2018 | 527 | 0.120 |
Why?
|
| Chemokine CCL20 | 1 | 2014 | 64 | 0.110 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2017 | 20600 | 0.110 |
Why?
|
| Signal Transduction | 1 | 2017 | 23415 | 0.110 |
Why?
|
| Granular Cell Tumor | 1 | 2014 | 48 | 0.110 |
Why?
|
| Receptors, CCR6 | 1 | 2014 | 74 | 0.110 |
Why?
|
| Perioperative Period | 1 | 2015 | 252 | 0.110 |
Why?
|
| Huntington Disease | 3 | 1995 | 1145 | 0.110 |
Why?
|
| Genes, APC | 1 | 2014 | 145 | 0.110 |
Why?
|
| Gastrointestinal Stromal Tumors | 1 | 2019 | 617 | 0.110 |
Why?
|
| Receptors, Muscarinic | 1 | 1994 | 157 | 0.110 |
Why?
|
| CA-125 Antigen | 1 | 2016 | 276 | 0.110 |
Why?
|
| Prebiotics | 1 | 2013 | 41 | 0.110 |
Why?
|
| Neostriatum | 1 | 1995 | 247 | 0.110 |
Why?
|
| Hepatectomy | 1 | 2017 | 557 | 0.110 |
Why?
|
| Incidence | 4 | 2016 | 21357 | 0.110 |
Why?
|
| Deglutition Disorders | 1 | 2019 | 627 | 0.110 |
Why?
|
| Dilatation, Pathologic | 1 | 2015 | 527 | 0.110 |
Why?
|
| Dissent and Disputes | 1 | 2014 | 147 | 0.110 |
Why?
|
| Dissection | 1 | 2015 | 297 | 0.110 |
Why?
|
| Kainic Acid | 5 | 1997 | 203 | 0.110 |
Why?
|
| Preoperative Period | 1 | 2015 | 551 | 0.110 |
Why?
|
| Cholecystectomy, Laparoscopic | 1 | 2015 | 231 | 0.100 |
Why?
|
| Angiography | 2 | 2017 | 1597 | 0.100 |
Why?
|
| Laryngeal Nerves | 2 | 1989 | 57 | 0.100 |
Why?
|
| Microvessels | 1 | 2017 | 580 | 0.100 |
Why?
|
| Spectrum Analysis | 1 | 2014 | 449 | 0.100 |
Why?
|
| Gallstones | 1 | 2015 | 284 | 0.100 |
Why?
|
| p300-CBP Transcription Factors | 1 | 2013 | 150 | 0.100 |
Why?
|
| Translocation, Genetic | 1 | 2018 | 1391 | 0.100 |
Why?
|
| Aging | 2 | 2011 | 8701 | 0.100 |
Why?
|
| Biotin | 2 | 1997 | 251 | 0.100 |
Why?
|
| Lac Operon | 1 | 1992 | 237 | 0.100 |
Why?
|
| Diagnostic Errors | 2 | 2016 | 1265 | 0.100 |
Why?
|
| Receptors, Dopamine | 1 | 1992 | 296 | 0.100 |
Why?
|
| Time Factors | 4 | 2019 | 39953 | 0.100 |
Why?
|
| Liposarcoma | 1 | 2014 | 289 | 0.100 |
Why?
|
| Intestinal Neoplasms | 1 | 2014 | 314 | 0.100 |
Why?
|
| Vestibular Nuclei | 1 | 1991 | 22 | 0.100 |
Why?
|
| Risk Assessment | 4 | 2019 | 24013 | 0.100 |
Why?
|
| Pancreatectomy | 1 | 2016 | 811 | 0.090 |
Why?
|
| Recurrent Laryngeal Nerve | 2 | 1989 | 143 | 0.090 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 2015 | 592 | 0.090 |
Why?
|
| Young Adult | 8 | 2016 | 59199 | 0.090 |
Why?
|
| Sex Distribution | 1 | 2016 | 2278 | 0.090 |
Why?
|
| Endosonography | 1 | 2015 | 608 | 0.090 |
Why?
|
| Early Diagnosis | 1 | 2016 | 1187 | 0.090 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2016 | 571 | 0.090 |
Why?
|
| Isocitrate Dehydrogenase | 1 | 2017 | 937 | 0.090 |
Why?
|
| Alu Elements | 1 | 2011 | 115 | 0.090 |
Why?
|
| Demography | 1 | 2015 | 1643 | 0.090 |
Why?
|
| Multivariate Analysis | 2 | 2015 | 12058 | 0.090 |
Why?
|
| Postoperative Period | 1 | 2015 | 1818 | 0.090 |
Why?
|
| Rad51 Recombinase | 1 | 2011 | 189 | 0.090 |
Why?
|
| Age Factors | 4 | 2016 | 18385 | 0.080 |
Why?
|
| Triazoles | 1 | 2015 | 903 | 0.080 |
Why?
|
| Probiotics | 1 | 2013 | 378 | 0.080 |
Why?
|
| Microcirculation | 1 | 2014 | 1280 | 0.080 |
Why?
|
| Colonic Polyps | 1 | 2014 | 553 | 0.080 |
Why?
|
| Age of Onset | 1 | 2016 | 3307 | 0.080 |
Why?
|
| Stem Cells | 2 | 2015 | 3512 | 0.080 |
Why?
|
| Asia | 1 | 2011 | 621 | 0.080 |
Why?
|
| Cyclophosphamide | 1 | 2015 | 2219 | 0.080 |
Why?
|
| Retinal Degeneration | 1 | 2013 | 414 | 0.080 |
Why?
|
| Postoperative Care | 1 | 2015 | 1469 | 0.080 |
Why?
|
| Colonoscopy | 2 | 2014 | 1398 | 0.080 |
Why?
|
| DNA Mutational Analysis | 1 | 2017 | 4109 | 0.080 |
Why?
|
| Lung Volume Measurements | 1 | 1989 | 375 | 0.080 |
Why?
|
| Simplexvirus | 1 | 1992 | 801 | 0.080 |
Why?
|
| Eyelid Neoplasms | 1 | 2009 | 89 | 0.080 |
Why?
|
| Cross-Cultural Comparison | 1 | 2011 | 634 | 0.070 |
Why?
|
| Laparoscopy | 1 | 2019 | 2030 | 0.070 |
Why?
|
| Early Detection of Cancer | 3 | 2017 | 3196 | 0.070 |
Why?
|
| Endoscopy | 2 | 2015 | 1852 | 0.070 |
Why?
|
| Pancreatic Neoplasms | 2 | 2016 | 5366 | 0.070 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2023 | 9278 | 0.070 |
Why?
|
| Catheter Ablation | 4 | 2017 | 2751 | 0.070 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2011 | 646 | 0.070 |
Why?
|
| Diagnosis, Differential | 4 | 2016 | 12975 | 0.070 |
Why?
|
| Decerebrate State | 4 | 1997 | 42 | 0.070 |
Why?
|
| North America | 1 | 2011 | 1281 | 0.070 |
Why?
|
| DNA | 2 | 2013 | 7189 | 0.070 |
Why?
|
| Autopsy | 1 | 2011 | 1010 | 0.070 |
Why?
|
| Incidental Findings | 1 | 2012 | 698 | 0.070 |
Why?
|
| Chi-Square Distribution | 1 | 2013 | 3419 | 0.070 |
Why?
|
| Cell Proliferation | 3 | 2018 | 10421 | 0.070 |
Why?
|
| Antigens, CD34 | 1 | 2009 | 655 | 0.070 |
Why?
|
| Neoplasm Metastasis | 1 | 2017 | 4908 | 0.070 |
Why?
|
| Colectomy | 1 | 2011 | 686 | 0.070 |
Why?
|
| Databases, Factual | 2 | 2019 | 7969 | 0.070 |
Why?
|
| Recombination, Genetic | 1 | 2011 | 1518 | 0.070 |
Why?
|
| Fluorouracil | 1 | 2011 | 1642 | 0.070 |
Why?
|
| Rats | 9 | 2013 | 23713 | 0.060 |
Why?
|
| Corpus Striatum | 1 | 1992 | 1235 | 0.060 |
Why?
|
| Health | 1 | 2008 | 398 | 0.060 |
Why?
|
| Facial Nerve | 1 | 1988 | 277 | 0.060 |
Why?
|
| Stem Cell Transplantation | 2 | 2006 | 1600 | 0.060 |
Why?
|
| Rats, Sprague-Dawley | 6 | 2013 | 8164 | 0.060 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2018 | 17889 | 0.060 |
Why?
|
| Adolescent | 6 | 2016 | 88271 | 0.060 |
Why?
|
| Vagotomy | 2 | 1997 | 83 | 0.060 |
Why?
|
| Gastrointestinal Neoplasms | 2 | 2010 | 955 | 0.060 |
Why?
|
| Up-Regulation | 1 | 2013 | 4111 | 0.060 |
Why?
|
| Hypercapnia | 4 | 1996 | 261 | 0.060 |
Why?
|
| Disease Susceptibility | 1 | 2011 | 1790 | 0.060 |
Why?
|
| Europe | 1 | 2011 | 3422 | 0.060 |
Why?
|
| SEER Program | 3 | 2015 | 1450 | 0.060 |
Why?
|
| Microscopy, Confocal | 1 | 2010 | 1967 | 0.060 |
Why?
|
| Insurance, Health | 1 | 2016 | 2494 | 0.060 |
Why?
|
| Gastrointestinal Tract | 1 | 2010 | 834 | 0.060 |
Why?
|
| Microscopy | 1 | 2009 | 904 | 0.050 |
Why?
|
| Nerve Tissue Proteins | 2 | 1995 | 4405 | 0.050 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2014 | 3493 | 0.050 |
Why?
|
| Coloring Agents | 2 | 2019 | 562 | 0.050 |
Why?
|
| Cell Line, Tumor | 2 | 2017 | 16947 | 0.050 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2013 | 2892 | 0.050 |
Why?
|
| Lung Neoplasms | 2 | 2009 | 13382 | 0.050 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2015 | 2157 | 0.050 |
Why?
|
| Bacteria | 1 | 2013 | 2190 | 0.050 |
Why?
|
| Immunosuppressive Agents | 1 | 2015 | 4189 | 0.050 |
Why?
|
| Animals | 21 | 2018 | 168083 | 0.050 |
Why?
|
| Massachusetts | 2 | 2016 | 8836 | 0.050 |
Why?
|
| Spinal Nerves | 2 | 1993 | 90 | 0.050 |
Why?
|
| Neurons | 5 | 1997 | 9435 | 0.050 |
Why?
|
| DNA, Neoplasm | 1 | 2007 | 1743 | 0.050 |
Why?
|
| Fetal Tissue Transplantation | 1 | 2002 | 138 | 0.050 |
Why?
|
| Cell Differentiation | 1 | 2018 | 11505 | 0.050 |
Why?
|
| Disease Management | 1 | 2011 | 2508 | 0.050 |
Why?
|
| Animals, Newborn | 2 | 1997 | 2666 | 0.050 |
Why?
|
| Mice, Inbred NOD | 2 | 2018 | 1822 | 0.050 |
Why?
|
| Heart | 2 | 2006 | 4431 | 0.040 |
Why?
|
| Colon | 1 | 2009 | 1791 | 0.040 |
Why?
|
| Rats, Inbred Strains | 2 | 1992 | 2087 | 0.040 |
Why?
|
| Tissue Array Analysis | 2 | 2013 | 550 | 0.040 |
Why?
|
| Iodides | 1 | 2019 | 39 | 0.040 |
Why?
|
| Phenotype | 1 | 2018 | 16572 | 0.040 |
Why?
|
| Escherichia coli | 1 | 1992 | 4205 | 0.040 |
Why?
|
| Nuclear Proteins | 2 | 2013 | 5781 | 0.040 |
Why?
|
| Neoplasm Proteins | 1 | 2011 | 3594 | 0.040 |
Why?
|
| Deglutition | 1 | 2020 | 208 | 0.040 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2022 | 569 | 0.040 |
Why?
|
| Cell Nucleus | 2 | 2011 | 2881 | 0.040 |
Why?
|
| Embryonic Stem Cells | 1 | 2006 | 1246 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 2 | 2018 | 6123 | 0.040 |
Why?
|
| Myocarditis | 1 | 2006 | 792 | 0.040 |
Why?
|
| Genome, Human | 1 | 2011 | 4423 | 0.040 |
Why?
|
| Epithelium | 2 | 2015 | 1603 | 0.040 |
Why?
|
| Image Cytometry | 2 | 2008 | 53 | 0.040 |
Why?
|
| Disease Models, Animal | 2 | 2015 | 18217 | 0.040 |
Why?
|
| Equipment Design | 2 | 2020 | 3509 | 0.040 |
Why?
|
| Capsule Endoscopes | 1 | 2016 | 13 | 0.040 |
Why?
|
| Reticular Formation | 1 | 1997 | 59 | 0.040 |
Why?
|
| Carcinoma, Signet Ring Cell | 1 | 2017 | 82 | 0.030 |
Why?
|
| Brain Stem | 3 | 1993 | 858 | 0.030 |
Why?
|
| In Situ Hybridization | 3 | 1995 | 1900 | 0.030 |
Why?
|
| Excitatory Amino Acid Agonists | 1 | 1997 | 142 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2018 | 3591 | 0.030 |
Why?
|
| Postoperative Complications | 2 | 2016 | 15634 | 0.030 |
Why?
|
| Image Enhancement | 1 | 2007 | 2888 | 0.030 |
Why?
|
| Cytokines | 2 | 2015 | 7386 | 0.030 |
Why?
|
| Microinjections | 1 | 1997 | 321 | 0.030 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2011 | 5300 | 0.030 |
Why?
|
| Conscious Sedation | 1 | 2020 | 533 | 0.030 |
Why?
|
| Keratin-7 | 1 | 2015 | 55 | 0.030 |
Why?
|
| Keratin-5 | 1 | 2015 | 45 | 0.030 |
Why?
|
| Muramidase | 1 | 2015 | 165 | 0.030 |
Why?
|
| Sensitivity and Specificity | 3 | 2017 | 14676 | 0.030 |
Why?
|
| Efferent Pathways | 2 | 1993 | 165 | 0.030 |
Why?
|
| Prevalence | 1 | 2012 | 15717 | 0.030 |
Why?
|
| Histocytochemistry | 2 | 1997 | 697 | 0.030 |
Why?
|
| Combined Modality Therapy | 3 | 2013 | 8519 | 0.030 |
Why?
|
| Hyperoxia | 1 | 1997 | 258 | 0.030 |
Why?
|
| Follow-Up Studies | 5 | 2016 | 39121 | 0.030 |
Why?
|
| Quinuclidinyl Benzilate | 1 | 1994 | 19 | 0.030 |
Why?
|
| SOX9 Transcription Factor | 1 | 2015 | 145 | 0.030 |
Why?
|
| Mutation | 2 | 2017 | 30006 | 0.030 |
Why?
|
| Brain | 4 | 1995 | 27097 | 0.030 |
Why?
|
| Cell Transdifferentiation | 1 | 2015 | 186 | 0.030 |
Why?
|
| Pirenzepine | 1 | 1994 | 116 | 0.030 |
Why?
|
| Length of Stay | 2 | 2019 | 6420 | 0.030 |
Why?
|
| Autoradiography | 1 | 1994 | 729 | 0.030 |
Why?
|
| Adamantane | 1 | 1994 | 148 | 0.030 |
Why?
|
| Benzoquinones | 1 | 2013 | 198 | 0.030 |
Why?
|
| Surgical Instruments | 1 | 2015 | 383 | 0.030 |
Why?
|
| Neurites | 1 | 1995 | 391 | 0.030 |
Why?
|
| RNA, Messenger | 4 | 2014 | 12743 | 0.030 |
Why?
|
| Rats, Long-Evans | 1 | 2013 | 381 | 0.030 |
Why?
|
| Binding, Competitive | 1 | 1994 | 1139 | 0.030 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 2015 | 476 | 0.030 |
Why?
|
| Photoreceptor Cells | 1 | 2013 | 235 | 0.030 |
Why?
|
| Thalamic Nuclei | 1 | 1992 | 111 | 0.030 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2015 | 450 | 0.030 |
Why?
|
| Axonal Transport | 1 | 1992 | 178 | 0.020 |
Why?
|
| Mucins | 1 | 2015 | 569 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2015 | 41486 | 0.020 |
Why?
|
| Lactams, Macrocyclic | 1 | 2013 | 318 | 0.020 |
Why?
|
| Cell Membrane | 2 | 2009 | 3665 | 0.020 |
Why?
|
| Esophagitis | 1 | 2013 | 165 | 0.020 |
Why?
|
| Interleukin Receptor Common gamma Subunit | 1 | 2011 | 87 | 0.020 |
Why?
|
| Cerebellar Nuclei | 1 | 1991 | 51 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 2014 | 1703 | 0.020 |
Why?
|
| Peritoneum | 1 | 2012 | 225 | 0.020 |
Why?
|
| beta-Galactosidase | 1 | 1992 | 574 | 0.020 |
Why?
|
| Mice | 6 | 2018 | 81324 | 0.020 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2009 | 5318 | 0.020 |
Why?
|
| Limbic System | 1 | 1992 | 419 | 0.020 |
Why?
|
| Apoptosis | 2 | 2018 | 9478 | 0.020 |
Why?
|
| Electrophysiology | 1 | 1993 | 1263 | 0.020 |
Why?
|
| Tissue Distribution | 1 | 1994 | 2262 | 0.020 |
Why?
|
| Vagus Nerve | 2 | 1989 | 458 | 0.020 |
Why?
|
| Pituitary Gland | 1 | 1992 | 635 | 0.020 |
Why?
|
| Glutamates | 1 | 1991 | 385 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2014 | 2468 | 0.020 |
Why?
|
| Basal Ganglia | 1 | 1992 | 554 | 0.020 |
Why?
|
| United States | 3 | 2015 | 72337 | 0.020 |
Why?
|
| Aneuploidy | 1 | 2013 | 555 | 0.020 |
Why?
|
| Chemoreceptor Cells | 1 | 1989 | 89 | 0.020 |
Why?
|
| Spleen | 1 | 2015 | 2290 | 0.020 |
Why?
|
| Neoadjuvant Therapy | 2 | 2011 | 2827 | 0.020 |
Why?
|
| Proctitis | 1 | 2009 | 40 | 0.020 |
Why?
|
| Motor Neurons | 2 | 1991 | 869 | 0.020 |
Why?
|
| Axons | 2 | 1997 | 1671 | 0.020 |
Why?
|
| Hospital Costs | 1 | 2015 | 947 | 0.020 |
Why?
|
| Loss of Heterozygosity | 1 | 2011 | 663 | 0.020 |
Why?
|
| Afferent Pathways | 1 | 1989 | 298 | 0.020 |
Why?
|
| Microscopy, Electron | 1 | 1992 | 2562 | 0.020 |
Why?
|
| Protein Biosynthesis | 1 | 1995 | 2091 | 0.020 |
Why?
|
| Endoscopes, Gastrointestinal | 1 | 2007 | 45 | 0.020 |
Why?
|
| Hypothalamus | 1 | 1992 | 999 | 0.020 |
Why?
|
| Fetus | 1 | 1994 | 1862 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2014 | 4565 | 0.020 |
Why?
|
| Pons | 1 | 1988 | 240 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2014 | 5033 | 0.020 |
Why?
|
| Chromosomal Instability | 1 | 2007 | 178 | 0.020 |
Why?
|
| Mice, SCID | 1 | 2011 | 2621 | 0.020 |
Why?
|
| Reproducibility of Results | 2 | 2018 | 20120 | 0.020 |
Why?
|
| Respiratory System | 1 | 1989 | 562 | 0.020 |
Why?
|
| Reference Values | 2 | 1995 | 4922 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2019 | 12341 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2017 | 9648 | 0.020 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2015 | 2802 | 0.020 |
Why?
|
| Fatal Outcome | 1 | 2009 | 1837 | 0.010 |
Why?
|
| Cytoplasm | 1 | 2009 | 1498 | 0.010 |
Why?
|
| Decision Support Techniques | 1 | 2014 | 2000 | 0.010 |
Why?
|
| Transfection | 1 | 1992 | 5750 | 0.010 |
Why?
|
| Base Sequence | 1 | 1995 | 12404 | 0.010 |
Why?
|
| Injections, Intravenous | 1 | 2006 | 1376 | 0.010 |
Why?
|
| Action Potentials | 1 | 1991 | 1834 | 0.010 |
Why?
|
| Organ Specificity | 1 | 1988 | 1963 | 0.010 |
Why?
|
| Synapses | 1 | 1992 | 1755 | 0.010 |
Why?
|
| Radiotherapy | 1 | 2009 | 1498 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 1995 | 17598 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2010 | 9001 | 0.010 |
Why?
|
| Socioeconomic Factors | 1 | 2016 | 7804 | 0.010 |
Why?
|
| RNA, Small Interfering | 1 | 2011 | 3409 | 0.010 |
Why?
|
| Video Recording | 1 | 2007 | 965 | 0.010 |
Why?
|
| Prospective Studies | 2 | 2018 | 54419 | 0.010 |
Why?
|
| B-Lymphocytes | 1 | 2015 | 4744 | 0.010 |
Why?
|
| Gene Expression | 1 | 1994 | 7567 | 0.010 |
Why?
|
| Isometric Contraction | 1 | 2002 | 150 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2013 | 10755 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2014 | 8639 | 0.010 |
Why?
|
| Myocardium | 2 | 2006 | 4746 | 0.010 |
Why?
|
| Glycoproteins | 1 | 2008 | 2203 | 0.010 |
Why?
|
| Cross-Sectional Studies | 2 | 2012 | 26068 | 0.010 |
Why?
|
| Myocardial Infarction | 1 | 2002 | 11475 | 0.010 |
Why?
|
| Logistic Models | 1 | 2015 | 13254 | 0.010 |
Why?
|
| Green Fluorescent Proteins | 1 | 2006 | 2061 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2018 | 22157 | 0.010 |
Why?
|
| Environmental Exposure | 1 | 2015 | 4479 | 0.010 |
Why?
|
| Myosin Heavy Chains | 1 | 2002 | 403 | 0.010 |
Why?
|
| Hippocampus | 1 | 1992 | 3757 | 0.010 |
Why?
|
| Intestines | 1 | 2008 | 1908 | 0.010 |
Why?
|
| Antineoplastic Agents | 2 | 2015 | 13630 | 0.010 |
Why?
|
| Societies, Medical | 1 | 2011 | 3923 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 1995 | 18926 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2014 | 14393 | 0.010 |
Why?
|
| Antigens, CD | 1 | 2008 | 4008 | 0.010 |
Why?
|
| Rats, Wistar | 1 | 2002 | 1850 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2013 | 9317 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 2015 | 10203 | 0.010 |
Why?
|
| Epithelial Cells | 1 | 2009 | 3666 | 0.010 |
Why?
|
| Diet | 1 | 2015 | 8047 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2006 | 6198 | 0.010 |
Why?
|
| Colitis, Ulcerative | 1 | 2009 | 1921 | 0.010 |
Why?
|
| Peptides | 1 | 2008 | 4353 | 0.010 |
Why?
|
| Myocardial Contraction | 1 | 2002 | 1516 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2014 | 22129 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2015 | 12096 | 0.010 |
Why?
|
| Cerebral Cortex | 1 | 1992 | 5777 | 0.010 |
Why?
|
| Algorithms | 1 | 2014 | 14023 | 0.010 |
Why?
|
| Embryonic and Fetal Development | 1 | 1994 | 420 | 0.010 |
Why?
|
| Nerve Fibers | 1 | 1997 | 707 | 0.010 |
Why?
|
| Child | 2 | 2011 | 80134 | 0.010 |
Why?
|
| Cell Survival | 1 | 2002 | 5776 | 0.010 |
Why?
|
| Hemodynamics | 1 | 2002 | 4164 | 0.010 |
Why?
|
| Graft Survival | 1 | 2002 | 3841 | 0.010 |
Why?
|
| Respiratory Muscles | 1 | 1989 | 142 | 0.000 |
Why?
|
| Ventricular Function, Left | 1 | 2002 | 3899 | 0.000 |
Why?
|
| Electrocardiography | 1 | 2002 | 6385 | 0.000 |
Why?
|
| Paralysis | 1 | 1989 | 250 | 0.000 |
Why?
|
| Radio Waves | 1 | 1989 | 251 | 0.000 |
Why?
|
| Analysis of Variance | 1 | 1995 | 6224 | 0.000 |
Why?
|
| Proteins | 1 | 1995 | 5993 | 0.000 |
Why?
|